Immunopathogenesis of inflammatory bowel disease: current concepts

被引:88
作者
Bamias, Giorgos
Cominelli, Fabio
机构
[1] Univ Virginia Hlth Syst, Digest Hlth Ctr Excellence, Charlottesville, VA 22908 USA
[2] Laikon Gen Hosp, Dept Propaedeut Med 1, Athens, Greece
关键词
Crohn's disease; innate immune system; Th17; ulcerative colitis;
D O I
10.1097/MOG.0b013e3281c55eb2
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Purpose of review According to the current paradigm, ulcerative colitis and Crohn's disease occur in genetically predisposed individuals because of dysregulated immune responses against intraluminal bacterial antigens. Data have recently accumulated supporting alternative hypotheses for the pathogenesis of inflammatory bowel disease. Here, we present novel immunogenetic pathways and discuss their impact on traditional understanding of inflammatory bowel disease. Recent findings In the gastrointestinal tract the innate immune system contains intraluminal bacteria locally, avoiding invasion of the deeper layers and preventing induction of long-standing proinflammatory responses. Failure of this protective function of the innate immune system appears to be the primary defect in inflammatory bowel disease, as a result of impairment of NOD2 signaling or other unidentified deficiencies. The adaptive immune response that ensues I was thought to be strictly differentiated between T-helper-1 mediated in Crohn's disease and T-helper-2 mediated in ulcerative colitis. This concept is rapidly changing, however, in light of recent evidence suggesting that tissue injury in inflammatory bowel disease is mediated by novel effector pathways, the most prominent of which is the interieukin-23/Th17 axis. Summary Elucidation of the pathways that underlie chronic intestinal inflammation will facilitate the development of new treatments with increased specificity and probably with decreased toxicity.
引用
收藏
页码:365 / 369
页数:5
相关论文
共 46 条
[1]   Interaction between interleukin-17-producing CD4+ T cells and colonic subepithelial myofibroblasts:: what are they doing in mucosal inflammation? [J].
Andoh, Akira ;
Ogawa, Atsuhir ;
Bamba, Shigem ;
Fujiyama, Yoshihide .
JOURNAL OF GASTROENTEROLOGY, 2007, 42 (Suppl 17) :29-33
[2]   New concepts in the pathophysiology of inflammatory bowel disease [J].
Bamias, G ;
Nyce, MR ;
De La Rue, SA ;
Cominelli, F .
ANNALS OF INTERNAL MEDICINE, 2005, 143 (12) :895-904
[3]   Proinflammatory effects of TH2 cytokines in a murine model of chronic small intestinal inflammation [J].
Bamias, G ;
Martin, C ;
Mishina, M ;
Ross, WG ;
Rivera-Nieves, J ;
Marini, M ;
Cominelli, F .
GASTROENTEROLOGY, 2005, 128 (03) :654-666
[4]   Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease [J].
Bamias, G ;
Martin, C ;
Marini, M ;
Hoang, S ;
Mishina, M ;
Ross, WG ;
Sachedina, MA ;
Friel, CM ;
Mize, J ;
Bickston, SJ ;
Pizarro, TT ;
Wei, P ;
Cominelli, F .
JOURNAL OF IMMUNOLOGY, 2003, 171 (09) :4868-4874
[5]   Commensal bacteria exacerbate intestinal inflammation but are not essential for the development of murine ileitis [J].
Bamias, Giorgos ;
Okazawa, Akira ;
Rivera-Nieves, Jesus ;
Arseneau, Kristen O. ;
De La Rue, Sarah A. ;
Pizarro, Theresa T. ;
Cominelli, Fabio .
JOURNAL OF IMMUNOLOGY, 2007, 178 (03) :1809-1818
[6]   Role of TL1A and its receptor DR3 in two models of chronic murine ileitis [J].
Bamias, Giorgos ;
Mishina, Margarita ;
Nyce, Mark ;
Ross, William G. ;
Kollias, Giorgos ;
Rivera-Nieves, Jesus ;
Pizarro, Theresa T. ;
Cominelli, Fabio .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (22) :8441-8446
[7]   The immunological and genetic basis of inflammatory bowel disease [J].
Bouma, G ;
Strober, W .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (07) :521-533
[8]   A phase 1/2A trial of STA 5326, an oral interleukin-12/23 inhibitor, in patients with active moderate to severe Crohn's disease [J].
Burakoff, Robert ;
Barish, Charles F. ;
Riff, Dennis ;
Pruitt, Ronald ;
Chey, William Y. ;
Farraye, Francis A. ;
Shafran, Ira ;
Katz, Seymour ;
Krone, Charles L. ;
Vander Vliet, Martha ;
Stevens, Christopher ;
Sherman, Matthew L. ;
Jacobson, Eric ;
Bleday, Ronald .
INFLAMMATORY BOWEL DISEASES, 2006, 12 (07) :558-565
[9]   Cytokine-based therapies for Crohn's disease - New paradigms [J].
Cominelli, F .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (20) :2045-2048
[10]   A genome-wide association study identifies IL23R as an inflammatory bowel disease gene [J].
Duerr, Richard H. ;
Taylor, Kent D. ;
Brant, Steven R. ;
Rioux, John D. ;
Silverberg, Mark S. ;
Daly, Mark J. ;
Steinhart, A. Hillary ;
Abraham, Clara ;
Regueiro, Miguel ;
Griffiths, Anne ;
Dassopoulos, Themistocles ;
Bitton, Alain ;
Yang, Huiying ;
Targan, Stephan ;
Datta, Lisa Wu ;
Kistner, Emily O. ;
Schumm, L. Philip ;
Lee, Annette T. ;
Gregersen, Peter K. ;
Barmada, M. Michael ;
Rotter, Jerome I. ;
Nicolae, Dan L. ;
Cho, Judy H. .
SCIENCE, 2006, 314 (5804) :1461-1463